I’m not sure why it has not received more attention in the medical device start-up world, but the Entrepreneur Access to Capital Act (EACA), which recently passed in the U.S. House of Representatives, has the potential to open the door to intriguing fundraising possibilities for individual medical device innovators and start-ups. Read More
In a recent post on PEHUB (Private Equity Hub), John Lonergan, Managing Member of Mach Ventures, made the case for virtual medical device product development. Mach Ventures’ business model is “we sell our medical devices just after we’ve proven that they work, or after FDA approval—no infrastructure, no management, and no duplication that the acquirer needs to get rid of.” Although he doesn’t use the term, that sounds virtual to me.
Read More
The standard for start-up companies these days, even prior to demonstrating feasibility, seems to be hiring a full operational management team. Considering the long clinical and regulatory pathway for novel medical devices, is there a justification for a dedicated executive team from the outset? Read More
